Single-cell resolution
We harness the richness of single-cell multiomics data to explain complex biological processes
Artificial Intelligence
We apply AI for unbiased, innovative, sensitive, and integrative multiomics data analysis
Biomarker discovery
We deliver translatable biomarker signatures related to therapy response, diagnosis or disease severity
We ensure the success of your biomarker discovery project
Faster time-to-insights for accelerated biomarker discovery
End-to-end single-cell data generation to data insights within a few weeks
Sensitive and specific biomarker discovery
We reach high discovery success rates with our best-in-class AI algorithm, using a sensitive, specific, indication- and data- agnostic analysis approach
Fully transparent and explainable results
Our AI platform retains single-cell resolution throughout the analysis and allows scientists to explore how genes or proteins drive predictions, thereby opening the “black box”
Scailyte is a Swiss-based start-up specialized in generating actionable insights/biosignatures from multi-omics single-cell data using AI. Our AI platform, ScaiVision, combines features to integrate different datasets, is indication- and cell-type agnostic and uses data augmentation and a cluster-free approach to extract relevant information while retaining single-cell resolution. These features result in very high discovery success rates from a limited number of samples, with actionable insights for the basis of assay development.
For Cell & Gene Therapy companies
For Immuno-Oncology, Inflammation and Immunology companies
Partner Testimonials
Prof. Dr Michael Mueller
Leading Clinician in Women’s Health & Scientific Advisor
Pascal Koenig
Entrepreneur & Chairman of the Board of Directors
Dominique Mégret
Scailyte Board of Directors & Head Swisscom Ventures
Prof. Woong-Yang Park
Founder and CEO of Geninus
Recent News
Recent News
Future Labs Live 2023
Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...
Recent News
The psychological and economic impact of endometriosis
We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...
Recent News
Jan Lichtenberg joins Scailyte's Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...
Recent News
Challenges and opportunities for innovation in Endometriosis
Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...
Recent News
Swiss Biotech Day 2023
Sarah Carl will be a panellist at the Swiss Biotech Association's Swiss Biotech Day 2023 on April 24...
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica...
Recent News
Women's Health Innovation Summit
Exciting news from Scailyte! We are thrilled to announce that we have been selected among the top 15...
Recent News
ISCT 2023
Diana Stoycheva and Filipa Teixeira will be attending the ISCT 2023 Annual Meeting from 31st May to ...
Future Labs Live 2023
Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...
Recent News
The psychological and economic impact of endometriosis
We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...
Jan Lichtenberg joins Scailyte's Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...
Recent News
Challenges and opportunities for innovation in Endometriosis
Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...
Swiss Biotech Day 2023
Sarah Carl will be a panellist at the Swiss Biotech Association's Swiss Biotech Day 2023 on April 24...
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica...
Women's Health Innovation Summit
Exciting news from Scailyte! We are thrilled to announce that we have been selected among the top 15...